EWA
CABA icon

EverSource Wealth Advisors’s Cabaletta Bio CABA Stock Holding History

EverSource Wealth Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-41
Closed -$62 – 4342
2025
Q2 		$62 Sell
41
-49
-54% -$76 ﹤0.01% 4175
2025
Q1 		$125 Buy
+90
New +$192 ﹤0.01% 3785
2024
Q3 		– Sell
-72
Closed -$511 – 3043
2024
Q2 		$511 Buy
+72
New +$883 ﹤0.01% 2890

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

EverSource Wealth Advisors's CABA Position: Q3 2025 in Review

EverSource Wealth Advisors sold out of Cabaletta Bio (CABA) in Q3 2025, closing a stake of 41 shares — an estimated $62 sold.

EverSource Wealth Advisors first reported a position in CABA in Q2 2024 and held it in 3 quarters. The position peaked at $511 in Q2 2024. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

  • EverSource Wealth Advisors reported no remaining Cabaletta Bio position as of Q3 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 41 Cabaletta Bio shares in Q3 2025, an estimated $62.
  • EverSource Wealth Advisors first reported a position in Cabaletta Bio in Q2 2024 and held it in 3 quarters.
  • EverSource Wealth Advisors's Cabaletta Bio position peaked at $511 in Q2 2024.
  • 75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.